831 Bransten Road
About BioTrace MedicalBioTrace Medical, a venture backed company based in San Carlos, Calif., is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs.
Founder: Ellis Garai
Founder: Aravind Swaminathan
President & CEO: Laura N. Dietch
10 articles with BioTrace Medical
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43rd Annual Meeting
Experience with BioTrace Medical’s Tempo Temporary Pacing Lead in Mitral Valve Surgeries Presented at Society of Cardiovascular Anesthesiologists’ 43 rd Annual Meeting
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the 31st annual Transcatheter Cardiovascular Therapeutics (TCT) conference, which will take place September 25-29 in San Francisco.
New TAVR standard of care technology to be featured in lunch symposium, live cases, and podium presentation
BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing.
Company’s Tempo Temporary Pacing Lead Has Been Used in More Than 1,500 Procedures with No Perforations – New Standard of Care in TAVR Demonstrates Safe Ambulation and Contributes to Reduced Length of Stay
Presentations Will Highlight Use of Tempo Lead as New Standard of Care in Temporary Pacing That Results in Earlier Ambulation and Reduced Length of Stay
Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures
U.S. Multi-Center Study Confirms Previous Intra-Procedural Safety; Post-TAVR Temporary Pacing Demonstrates Ambulation Capabilities
BioTrace Medical’s Tempo Lead Shows Stability And Safety In Real-World Performance Consistent With Clinical Study Outcomes In TVT 2017 Presentation
BioTrace Medical Announces Positive Data From Clinical Study Of Innovative Temporary Pacing Technology For Transcatheter Aortic Valve Procedures And Other Cardiovascular Applications
Bay Area's BioTrace Medical Nabs FDA Clearance of Innovative Temporary Pacing Technology for the Heart